Artificial Intelligence in Drug Discovery
Een podcast door Simon Smith
12 Afleveringen
-
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Gepubliceerd: 7-8-2018 -
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Gepubliceerd: 7-8-2018 -
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Gepubliceerd: 30-7-2018 -
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Gepubliceerd: 26-7-2018 -
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Gepubliceerd: 18-7-2018 -
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Gepubliceerd: 10-7-2018 -
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Gepubliceerd: 28-6-2018 -
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Gepubliceerd: 20-6-2018 -
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Gepubliceerd: 11-6-2018 -
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Gepubliceerd: 29-5-2018 -
Mauro Cozzi, Researchably, AI for Better Biomedical Search
Gepubliceerd: 22-5-2018 -
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
Gepubliceerd: 14-5-2018
1 / 1
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
